Related Experiment Video
Updated: Jan 5, 2026

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS
Arjun Kalvala1, Pierre Wallet2, Lu Yang3
1Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. akalvala@coh.org.
Abstract:
Oncogenic (mutant) Ras protein Kirsten rat sarcoma viral oncogene homolog (KRAS) promotes uncontrolled proliferation, altered metabolism, and loss of genome integrity in a cell-intrinsic manner. Here, we demonstrate that CD4+ T cells when incubated with tumor-derived exosomes from mutant (MT) KRAS non-small-cell lung cancer (NSCLC) cells, patient sera, or a mouse xenograft model, induce phenotypic conversion to FOXP3+ Treg-like cells that are immune-suppressive. Furthermore, transfecting T cells with MT KRAS cDNA alone induced phenotypic switching and mathematical modeling supported this conclusion. Single-cell sequencing identified the interferon pathway as the mechanism underlying the phenotypic switch. These observations highlight a novel cytokine-independent, cell-extrinsic role for KRAS in T cell phenotypic switching. Thus, targeting this new class of Tregs represents a unique therapeutic approach for NSCLC. Since KRAS is the most frequently mutated oncogene in a wide variety of cancers, the findings of this investigation are likely to be of broad interest and have a large scientific impact.
Insights
Mutant KRAS in non-small-cell lung cancer (NSCLC) causes immune-suppressive T cells. This study reveals a new mechanism for KRAS in T cell changes, offering a novel therapeutic target for NSCLC.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Mutant Kirsten rat sarcoma viral oncogene homolog (KRAS) drives cancer progression through uncontrolled cell proliferation and altered metabolism.
- The role of KRAS in modulating the tumor microenvironment and immune cell function is not fully understood.
Purpose of the Study:
- To investigate the cell-extrinsic effects of mutant KRAS on T cell phenotype and function.
- To identify the underlying molecular mechanisms of KRAS-mediated T cell modulation in non-small-cell lung cancer (NSCLC).
Main Methods:
- Incubation of CD4+ T cells with tumor-derived exosomes, patient sera, and xenograft models from mutant KRAS NSCLC.
- Genetic manipulation of T cells with mutant KRAS cDNA.
- Single-cell sequencing and mathematical modeling to elucidate the mechanism.
Main Results:
- Exposure to mutant KRAS-associated factors induced a phenotypic conversion of CD4+ T cells to FOXP3+ regulatory T cell (Treg)-like, immune-suppressive cells.
- Direct transfection of T cells with mutant KRAS cDNA replicated this phenotypic switch.
- Single-cell sequencing identified the interferon pathway as the key mediator of this KRAS-induced T cell transformation.
Conclusions:
- Mutant KRAS exerts a novel, cytokine-independent, cell-extrinsic influence on T cell phenotype, promoting immune suppression.
- Targeting this KRAS-induced Treg-like cell population presents a promising therapeutic strategy for NSCLC.
- The findings have broad implications for KRAS-mutated cancers due to KRAS's frequent mutation across various malignancies.
Related Concept Videos
The Ras Gene
Ras is a...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Forced Transdifferentiation
Artificial...
Abnormal Proliferation
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

